Immune Regulation News 10.23 June 22, 2018 | |
![]() | |
| |
TOP STORYLSD1 Ablation Stimulates Anti-Tumor Immunity and Enables Checkpoint Blockade Researchers demonstrated that ablation of the histone demethylase LSD1 in cancer cells increases repetitive element expression, including endogenous retroviral elements, and decreases expression of RNA-induced silencing complex components. This lead to double-stranded RNA stress and activation of type 1 interferon, which stimulated anti-tumor T cell immunity and restrained tumor growth. [Cell] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)The authors found that Il17f–/– mice resisted chemically induced colitis, but Il17a–/– mice did not, and that Il17f–/– CD45RBhiCD4+ T cells induced milder colitis in lymphocyte-deficient Rag2–/– mice, accompanied by an increase in intestinal Treg cells. [Nat Immunol] Abstract Using the newly identified microglia marker P2ry12 and microglial depletion strategies, they demonstrated that retinal microglia are rapidly activated in response to retinal detachment (RD) and migrated into the injured area within 24 hours post-RD, where they closely associate with infiltrating macrophages, a population distinct from microglia. [Proc Natl Acad Sci USA] Full Article The authors investigated whether cancer-associated fibroblasts can regulate tumor-infiltrating lymphocytes and their role in tumor immunosuppression. [Clin Cancer Res] Abstract Researchers showed a role for IL-2 triggering IL-17 production by lung granular γδ T cells as IL-17 synthesis and neutrophil recruitment was reduced by IL-2 blocking mAbs in vitro and in vivo. [Mucosal Immunol] Abstract Scientists report that retrieving the balance between Smad3 and Smad7 signaling with asiatic acid and naringenin effectively inhibited tumor progression in mouse models of invasive melanoma and lung carcinoma by promoting NK cell development and cytotoxicity against cancer. They found that Smad3 physically bound Id2 and IRF2 to suppress NK cell production and NK cell-mediated cytotoxicity against cancer. [Mol Ther] Abstract Investigators identified the immunomodulatory role of induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) on resting peripheral blood mononuclear cells (PBMCs) from allergic rhinitis patients. PBMCs were cocultured with iPSC-MSCs without any stimulation, following which lymphocyte proliferation, activation of T cells, TH1/TH2 and Treg cell differentiation, and Treg cell function were analyzed. [Stem Cell Res Ther] Full Article In vitro stimulation of acid sphingomyelinase (ASM)-deficient T cells in the presence of TGF-β and IL-2 leads to higher numbers of induced Treg cells. Pharmacological inhibition of the ASM with a clinically used tricyclic antidepressant such as amitriptyline in mice or in tissue culture of murine or human T cells induced higher frequencies of Treg cells among CD4+ T cells within a few days. [Biol Chem] Abstract Investigators showed that interleukin‐2 promotes the development of FOXP3+ thymocytes and enhances their survival at the double positive (DP) phase. IL‐2 increased the frequency of FOXP3+ cells and promoted the Treg phenotype after TCR‐mediated positive selection at the most mature DP stage. [Scand J Immunol] Abstract Compared to controls, colorectal cancer patients presented mild upregulations in CD4+CD25+/hi T cells and in the more canonical CD4+CD25+/hiFoxp3+ Treg cells in peripheral blood mononuclear cells. [Clin Exp Pharmacol Physiol] Abstract Subscribe to our sister publications: Human Immunology News & Immunology of Infectious Disease News. | |
| |
REVIEWSRegulatory T Cells in Autoimmune Disease The authors summarize the newer concepts of Treg cell instability, Treg cell plasticity and tissue-specific Treg cells, and their relationship to autoimmunity. [Nat Immunol] Abstract Visit our reviews page to see a complete list of reviews in the immune regulation research field. | |
| |
SCIENCE NEWSTxCell: First In Vivo Proof-of-Concept Data with CD8+ CAR-Treg Presented TxCell SA announced that Dr. Carole Guillonneau, PhD, will present proof-of-concept preclinical data, generated by TxCell and CRTI. [Press release from TxCell SA discussing research presented at the 2018 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), San Francisco] Press Release | |
| |
INDUSTRY NEWSCrown Bioscience announced that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline. [Crown Bioscience] Press Release Jeffrey Modell Foundation Awards $3.7 Million for Global Primary Immunodeficiency Research To date, $3.7 million has been awarded by the Jeffrey Modell Foundation for research into genetic immunodeficiency diseases known as Primary Immunodeficiency. Research programs focus on translational research and support of underserved regions with healthcare disparities, with projects currently being conducted in 32 countries led by 45 leading investigators. [Jeffrey Modell Foundation (PR Newswire Association LLC.)] Press Release Study into the Causes of Crohn’s Disease Hits Major Milestone After ten years and a worldwide effort, Crohn’s and Colitis Canada announced that the world-renowned Genetic, Environmental, Microbial (GEM) Project has reached its goal of 5,000 participants. Launched in 2008 at Mount Sinai Hospital in Toronto, the GEM Project is the world’s largest clinical study investigating the causes of Crohn’s disease. [Crohn’s & Colitis Canada] Press Release | |
| |
POLICY NEWSWhite House Proposes a Narrowing of FDA’s Mission — And a New Name The Trump administration has proposed a fundamental change to the mission of the Food and Drug Administration, one that would transfer most of the responsibility for regulating food safety to the Department of Agriculture and rename the FDA the “Federal Drug Administration.” [STAT News] Editorial Trump’s Plan to Reshuffle Government Strikes Familiar Notes President Donald Trump proposed reorganizing parts of the federal government in ways that should sound very familiar to those who follow U.S. science policy. The plan, labeled “Delivering Government Solutions in the 21st Century,” would affect federal research agencies in ways great and small. [ScienceInsider] Editorial Two University of Rochester Professors Resign in Protest Celeste Kidd, an associate professor in the University of Rochester’s brain and cognitive sciences department, announced her move to the University of California, Berkeley, earlier this month. Kidd and her husband, Steven Piantadosi—another professor at the university—are leaving in response to the university’s handling of the sexual harassment allegations against brain sciences professor Florian Jaeger. [The Scientist] Editorial Hundreds of U.S. Scientists Urge More Transparency in Animal Research Breaking with a history of reticence, nearly 600 scientists, students, and lab animal workers published a letter in USA Today that calls on U.S. research institutions to “embrace openness” about their animal research. [ScienceInsider] Editorial
| |
EVENTSNEW Infection and Chronic Disease Meeting NEW 47th Annual Scientific Meeting of the Australasian Society for Immunology Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellowships – Immunometabolism (St. Jude Children’s Research Hospital) NEW Assistant/Associate Professor – Immunology (University of Massachusetts) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) PhD Student – Cellular Immunotherapy (Glycostem Therapeutics) Postdoctoral Research Fellow – Human Systems Immunology (University of Oslo) PhD Student Positions – Immunology (Multiple Locations) Postdoctoral Research Scientist – Immunology (Lilly) Postdoctoral Fellowship – Immunology (University of South Carolina) Postdoctoral Fellow – Immunology (Boston University School of Medicine) Postdoctoral Fellow – Innate Immune Signaling (Houston Methodist Research Institute) Postdoctoral Associate Position – Tumor Immunology/Immunotherapy (Duke Cancer Institute) Assistant, Associate, or Full Member – Cancer Immunology (Fred Hutchinson Cancer Research Center) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|